chrisvoncsefalvay/vaers-outcomes huggingface dataset:
This spontaneous report as received from a registered nurse refers to unspecified patients of unknown age and gender. The patients' concurrent conditions, medical history and concomitant medications were not reported. On unknown dates, the patients were vaccinated with improperly stored ZOSTAVAX, lot # M032638, expiry date 04-OCT-2017 (dose, route and site of administration were not reported) for prophylaxis. No adverse effects were reported. Administered vaccines underwent a temperature excursion of 5 to 14 degrees Fahrenheit for 2 hours and 5 to 14 degrees Fahrenheit for 5 hours 10 minutes. This is one of several cases received from the same reporter. Additional information has been requested. Sender's Comments: US-009507513-1701USA007866: US-009507513-1701USA002418.
Tingling in left leg and toes; This is a spontaneous report from a contactable consumer, the patient. A 25-year-old, non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0167) via an unspecified route of administration in the arm left on 10Jul2021 (at the age of 25-year-old) as a single dose for COVID-19 immunisation. The patient had no medical history and no known allergies to medications, food or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive other medications in two weeks prior to the vaccination. The patient received DEPOPROVERA medication (reported as other vaccine received with in four weeks prior to COVID vaccine) for an unknown indication from 26Jul2021 and unknown if ongoing. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0191) via an unspecified route of administration in the arm left on an unknown date in 2021 as a single dose for COVID-19 immunisation. Since the vaccination, the patient had not been tested for COVID-19. On 31Jul2021 at 22:00, the patient experienced tingling in left leg and toes. No therapeutic measures were taken as a result of the event. The clinical outcome of the event tingling in left leg and toes was not recovered at the time of this report.
Approximately 24 hours after receiving dTap, Hep B, IPV, Hib, PCV, pt had axillary temp of 108 degrees farenheit per mom, then had a an episode of tense extremities, turned purple, had tonic-clonic activity lasting approximately 4 minutes per mom, had tmax od 104 degrees farenheit in the AD at hospital.  He was treated with antibiotics for 48 hours, had negative blood and urine cultures and an eeg.  11/16/07 Received vax record & VAERS database updated w/same.  12/4/07 Received hospital medical records which reveal patient experienced fever, diarrhea & dry cough x 1 day with one episode of  rigidity, cyanosis & tonic-clonic movements for approx 4 min while on the way to outlying ER.  Temp at home reported to be 108.  Transferred to higer level of care after received IV antibiotics in ER. Admittted 10/10-10/12/2007.  Peds neuro consult done.   FINAL DX: complicated febrile seizure and vaccination reaction.
20 min after dose of moderna vaccine she felt her face get hot and swollen and she felt tingling - 10 more minutes and she felt throat was swelling.  Waited another 20 min.  Went to ER.  Got full body shakes and a full body rash.  Given pred, benadryl, treated for anaphylaxis.  Symptoms began to recur next day and came to PCP office
Arthralgia PAIN/SWELLING INJ SITE Narrative:  Other Relevant History:
This spontaneous report as received from a Registered Nurse refers to a 66 year old male patient. Medical history and drug reactions or allergies were not reported. On 09-FEB-2015 the patient was vaccinated an expired dose of ZOSTAVAX lot # K000726 expiration date: 09-JAN-2015 (dose and route were not provided). Concomitant therapy was not reported. No adverse effects reported. Additional information has been requested.
Patient was seizing while in wheelchair 10 min after receiving her covid vaccination.  Moved to medical tent,  Seized for ~ 1.5 min.  follwed by 2 30 seccond seizures following initial .  Post ictal after seizures but airway maintained.  no other clinical complications noted.   pulse and BP was normal.  911 contacted transferred to Medical Center.
She was exposed to a COVID positive, then a day after her 1st dose she was exposed again. Now the caller is COVID positive and experienced a cold; She was exposed to a COVID positive, then a day after her 1st dose she was exposed again. Now the caller is COVID positive and experienced a cold; She was exposed to a COVID positive, then a day after her 1st dose she was exposed again. Now the caller is COVID positive and experienced a cold; This is a spontaneous report from a contactable consumer (Patient) via Pfizer-sponsored program.  A female patient of an unspecified age received first BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Formulation: Solution for injection, Lot number: Batch/Lot Number: unknown; Expiration Date: unknown), on an unspecified route of administration on 22Feb2021 as SINGLE DOSE for COVID-19 immunisation. The patient medical history and concomitant medications were not reported. The patient received her 1st dose on 22Feb2021, a day before she was exposed to a covid positive, then a day after her 1st dose she was exposed again. Now the patient is covid positive and experienced a cold. She wants to know will the vaccine help after all the exposure and what does she need to do not to expose others. At the time of this report event outcome was unknown.   Information about lot/ batch number has been requested.
Information has been received from a 64 year old female consumer with high blood pressure and high cholesterol who on 19-FEB-2009 was vaccinated with ZOSTAVAX (Merck) (lot number not reported). Concomitant therapy included blood pressure and cholesterol medications (manufacture unspecified). On approximately 26-FEB-2009, about a week later, the patient noticed she had swelling of her lymph nodes under the left shoulder blade and under right arm and she was having trouble swallowing. The consumer stated that she had spoken with her physician and was going to had a CAT scan on 24-MAR-2009l and a biopsy on 25-MAR-2009. The consumer sought unspecified medical attention. The consumer stated that the swelling of the lymph nodes were getting worse and not recovered. Additional information has been requested.
Doesn't feel like getting up; Diarrhea; Cramping along the lower gut; Has sweats; This spontaneous case was reported by a consumer and describes the occurrence of ASTHENIA (Doesn't feel like getting up), DIARRHOEA (Diarrhea), ABDOMINAL PAIN LOWER (Cramping along the lower gut) and HYPERHIDROSIS (Has sweats) in a 40-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced ASTHENIA (Doesn't feel like getting up), DIARRHOEA (Diarrhea), ABDOMINAL PAIN LOWER (Cramping along the lower gut) and HYPERHIDROSIS (Has sweats). At the time of the report, ASTHENIA (Doesn't feel like getting up), DIARRHOEA (Diarrhea), ABDOMINAL PAIN LOWER (Cramping along the lower gut) and HYPERHIDROSIS (Has sweats) outcome was unknown.            No concomitant medications were reported. No treatment medications were reported.   Most recent FOLLOW-UP information incorporated above includes: On 27-Jul-2021: Follow-up information received on 27-Jul-2021 and does not contain any new information.
pt recv vax 4APR95 & pt exp a large painful, discolored area @ inj site;It was present for approx 10 days;
Extreme pain in injected arm.  Pain in arm, shoulder and neck with shooting pain to fingers and sharp pain in shoulder and neck.
felt nauseated, fainted, eyes rolled back & tonic/clonic sz;movement for 60sec;started to arouse & speak p/2min;BP 112/70, P80;incontinent of urine, cannot remember anything other than & dry metalic taste in mouth;vasovagal rxn;
Ectopic Heart Beats; This is a spontaneous report received from contactable reporter(s) (Other HCP). The reporter is the patient.  A 69 year-old male patient received bnt162b2 (BNT162B2), administered in arm left, administration date 17Dec2020 09:00 (Lot number: EK5730) at the age of 69 years as dose 1, single for covid-19 immunisation. Relevant medical history included: "Gastrooesophageal reflux disease" (unspecified if ongoing). Concomitant medication(s) included: PROTONIX [OMEPRAZOLE]. Past drug history included: Latex, reaction(s): "Allergy". The following information was reported: EXTRASYSTOLES (non-serious) with onset 17Dec2020 20:00, outcome "not recovered", described as "Ectopic Heart Beats". The event "ectopic heart beats" was evaluated at the physician office visit. Therapeutic measures were not taken as a result of extrasystoles.  Additional information: Additional information: The patient received Dose 2 single, administered in arm left, administration date 08Jan2021 .The patient has not received any other vaccines within 4 weeks prior to the COVID vaccine, and Prior to vaccination. Prior to vaccination patient was not diagnosed with COVID-19, and Since the vaccination, the patient was not tested for COVID-19.  No follow-up attempts are possible. No further information is expected.
Bilateral 20-25 dB sensorineural hearing loss; onset approx 1 month p/immunization.
Patient felt numbness in their hands and legs. Patient was monitored for 1 hour. Patient was evaluated by EMS. Patient signed an RMA.
pt in early 20's recvd TD either SC or ID 17FEB93; devel area of erythema around inject site w/in 24 hrs as of 19FEB, area enlarging;
Initial report was received 12 August 2011 from a health care professional. A "30 or so" year old male patient had received a left deltoid injection of ADACEL on 25 July 2011 and an unspecified amount of time later, he developed pain, soreness and decreased range of motion in the vaccinated arm. No redness, swelling or other symptoms were present. One week later, the patient felt the pain had not improved, but became worse and the patient could not sleep on their left side. The event required a doctor's visit. The patient was a healthy young man with normal body/muscle mass who exercised and worked out daily. The vaccine had been administered in the usual manner and the same needle length had been used as for other adult patients (needle size not reported). Outcome was not recovered. Documents held by sender: None.
Patient reports that she developed red itchy rash on 4/10/18, first on back of neck and progressing down trunk, arms, and legs over course of one week. As of today 5/2/18, rash has subsided but itching remains on arms. Denies other signs of allergic reaction when questioned. Patient does have Hx of eczema.  Patient advised to contact primary physician to report incident. 2nd Shingles vaccination will be postponed by this clinic until physician determines reason for rash and clears patient to receive.
Fever for 2 to 3 weeks 103, tremors, chills, sweats, headaches, bladder infection
Rash on inner right arm, upper right arm, side of right breast and a couple of spots on abdomen; a couple spots on the  right side of her stomach; This is a spontaneous report from a contactable consumer. A 53-years-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for Injection, Batch/Lot number: FC3180) via an unspecified route of administration, administered in Arm Left on 17Aug2021 as DOSE 1, SINGLE (at the age of 53-year-old) for covid-19 immunisation. The patient's medical history included guillain-barre syndrome from 1992 to an unknown date History of GB syndrome in 1992. The patient's concomitant medications were not reported. It was reported that, patient got vaccine in left arm and right side has the rash on 19Aug2021. The rash was on her inner, upper right arm and on the outer side of her right breast. Patient also has a couple spots on the right side of her stomach. Patient  was currently taking Allegra twice/day for symptoms. Therapeutic measures were taken as a result of events. The outcome of the events was unknown.   Follow-up attempts are completed. No further information is expected.
Patient received Janssen COVID vaccine on 4/1/21. On 1/17/22, patient admitted to our inpatient facility (med/surg unit) with prolonged seizure, acute metabolic encephalopathy due to seizure, acute respiratory failure with hypoxia due to encephalopathy, and was found to be COVID positive during admission screening. He has no respiratory symptoms from COVID19 during hospitalization. Patient is anticipated to be discharged later today (1/21/22).
DAY AFTER INJECTION, DID HAVE REDNESS, FEVER IN THE AREA OF THE INJECTION.  ALSO FELT "OFF", BUT THAT STOPPED WITHING 2 DAYS.        TODAY 2/11/2021 - STILL HAVE A BIG KNOT THAT IS RED AND FEVER.  I DID TAKE A PICTURE TO MAKE KEEP TRACK OF REDNESS/ POSSIBLY SPREADING.
woke up next morning after booster shot with double vision; was admitted to the hospital 2 days later to r/o stroke, which was ruled out; Ophthalmologist diagnosed as 4th cranial nerve palsy. the double vision has yet to resolve
experiencing fever continued the fever for 6-7 days and measured always between 99-100 degree; "horrible, weak and hardly able to walk; felt "horrible, weak; This spontaneous case was reported by a consumer and describes the occurrence of GAIT INABILITY ("horrible, weak and hardly able to walk), ASTHENIA (felt "horrible, weak) and PYREXIA (experiencing fever continued the fever for 6-7 days and measured always between 99-100 degree) in an 85-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included Neck surgery (plate put in) on 15-Jan-2021. Concurrent medical conditions included Blood pressure abnormal. Concomitant products included ATORVASTATIN CALCIUM (STATIN [ATORVASTATIN CALCIUM]) and ASPIRIN [ACETYLSALICYLIC ACID] for an unknown indication.   On 26-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 25-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 26-Feb-2021, the patient experienced GAIT INABILITY ("horrible, weak and hardly able to walk) and ASTHENIA (felt "horrible, weak). On 27-Feb-2021, the patient experienced PYREXIA (experiencing fever continued the fever for 6-7 days and measured always between 99-100 degree). On 05-Mar-2021, PYREXIA (experiencing fever continued the fever for 6-7 days and measured always between 99-100 degree) had resolved. At the time of the report, GAIT INABILITY ("horrible, weak and hardly able to walk) and ASTHENIA (felt "horrible, weak) had not resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Body temperature: 99-100 (High) 99-100.     For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Action taken with mRNA-1273 in response to the events was not Applicable.
June 11th it began with upper respiratory symptoms; congestion, runny nose, sore throat. I then had a cough but not feeling really sick. The following day I felt crummy and then later had shaking chills and sweats and very fatigued. I also had a severe sore throat almost to the point where I could not swallow. June 13th took the test at home. Contacted doctor and was prescribed PAXLOVID beginning June 13. On June 13th I began taking prednisone for the sore throat. Over the next several days I began to feel better. Yet, as of today, June 30th, I am still unusually fatigued and not 100% yet.
Warmth of injection site; nausea; body aches; splitting headache; dizziness; Low grade fever; extreme tiredness; This is a spontaneous report from a contactable nurse, the patient. A 25-year-old female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE, Lot number EH9899), via an unspecified route of administration on 31Dec2020 at 10:00 (at the age of 25-years-old) as a single dose, in the right arm for COVID-19 vaccination. Medical history was not reported. The patient was not pregnant at the time of vaccination.  Prior to the vaccination, the patient was not diagnosed with COVID-19.  Concomitant medications included diphenhydramine hydrochloride (BENADRYL), ibuprofen, paracetamol (TYLENOL), and fexofenadine, all from unknown dates for unknown indications. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient previously took amoxicillin and famotidine, both from unknown dates to unknown dates for unknown indications, and experienced allergy. On 31Dec2020 at 17:00, the patient experienced warmth of injection site, body aches, splitting headache, dizziness, low grade fever, extreme tiredness, and nausea. The patient did not receive any treatment for the events. The clinical outcome of the events warmth of injection site, body aches, splitting headache, dizziness, low grade fever, extreme tiredness, and nausea was recovering. It was also reported that since the vaccination, the patient had not been tested for COVID-19.   No follow-up attempts are possible. No further information is expected.
This is a spontaneous report from a contactable consumer (patient). A 30-year-old male patient received the second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on 22Mar2021 (Lot Number: EJ1685) at the age of 29 years as single dose and the first dose of bnt162b2, via an unspecified route of administration on 01Mar2021 (Lot Number: EK5730) at the age of 29 years as single dose for Covid-19 immunisation. The patient medical history and concomitant medications were not reported. Household family member was positive for COVID. Pfizer colleague wellness labeled patient as presumed positive. Patient was experiencing the following symptoms: fever, chills, sweats, headache, and a cough. Adverse event start date was 09Oct2021. No treatment was received. Covid (Nasal Swab) tested post vaccination was negative. Outcome of events were recovering.   Follow-up attempts are completed. No further information is expected.
Left eye blurry vision and left eye deviation (intermittent); feels "queezy" and dizzy with diplopia. This began about 02:00 and continued on this morning. Resolved in about 24 hours.
Woke up to extreme back pain a week later loss control of muscles and ascending paralysis and diagnosed with Guillain-Barre Syndrome resulting from the recent vaccination.
pt recv vax DEC95 & 31MAY96 pt exp chicken pox w/approx 30 lesions the second day of onset;tx w/DPH & unspecified topical agents;
Information has been received from a nurse concerning a female who in April 2008, was vaccinated with her second dose of GARDASIL vaccine (yeast) (lot# unknown, route and site not reported). Subsequently the patient experienced bumps on her hips. The patient had heard the news media about all the adverse events experienced with GARDASIL vaccine and called the doctor's office to report the bumps on her hips.. The patient's bumps on her hips persisted. No other information was available. Additional information has been requested.
Hospitalized 04/07/2022-04/11/2022; COVID-19 positive 04/07/2022; fully vaccinated plus booster  BRIEF OVERVIEW: Discharge Provider: MD Primary Care Provider at Discharge: MD   Admission Date: 4/7/2022 Discharge Date: 4/11/2022 DETAILS OF HOSPITAL STAY: PRESENTING PROBLEM: Hypoxia [R09.02] Pneumonia due to COVID-19 virus [U07.1, J12.82] COVID-19 [U07.1]   HOSPITAL COURSE: Patient is a 85 y.o. male admitted with worsening dyspnea from COVID-19..Patient was previously vaccinated for COVID-19. Initially, he developed symptoms on March 8th.  Had positive COVID test on March 12. At that time felt he was recovered from the illness and was doing better.       Over the previous 2-3 weeks prior to admission he had significant worsening of of symptoms including shortness of breath, increasing fatigue, malaise, body aches, intermittently productive cough with yellow sputum, and exertional dyspnea.  In recent weeks, seen by his primary care provider and given antibiotics for suspected bacterial pneumonia.     In addition, patient was admitted to Hospital April 1st for suspected acute CVA.  No evidence of acute brain CVA/ injury noted.  Positive COVID test again noted at that time.  Chest x-ray-April 1st, showed stringyand patch infiltrates.  Patient was discharged home.    Emergency department patient was tachycardic mildly hypotensive and on 2 L per nasal cannula.  Chest x-ray appearance was consistent with COVID-19 pneumonia.  Patient was outside the window of and the severe but admitted to hospital and placed on IV Decadron.  During hospitalization oxygenation initially worsen to up to 6 L per nasal cannula.  Patient was given gentle diuresis with good results.  Patient's oxygenation started to improve and over a 2 day.  Patient went from 6 L per nasal cannula to room air.  Prior to discharge patient did have a home oxygen evaluation and maintain adequate oxygen saturations are 97%.  Patient is being discharged to home.  He will complete a 10 day course of steroids.  Patient should follow up with his primary care physician in 1 week.  Patient was evaluated by Occupational therapy and Physical therapy prior to discharge in May had no further recommendations.  Patient states he is doing well and is anxious for discharge to home.  Discharge instructions were explained all patient's questions were answered.  Course the patient has worsening shortness of breath worsening cough developed high fevers chills or feels his clinical condition is deteriorating in any way he should call his primary care physician or return to the emergency department immediately for further evaluation
Injection administered at 10:45 a.m. PDST on September 23, 2009; symptoms began upon awakening the morning of September 24, 2009.  Severe, large solid blocks of redness, tenderness and swelling covering most of upper arm (outside portion of upper arm) on arm that got the injection, severe pain lasting in excess of 4 days preventing patient from normal use of arm, red areas (very large and solid) very hot to the touch; area of arm involved keeps expanding and moving down arm, and as of 4 days after injection, now moving down the arm involving elbow joint and causing joint pain; areas of upper arm less red but still very sore and tender to the touch; Patient will visit doctor on Monday, September 28, 2009 because symptoms have not subsided and more area of arm has become involved (left arm)
A report has been received from a Health Professional concerning a 31 year old, female patient, who had been receiving FLUMIST Quadrivalent (intranasal), 0.2 milliliters, unknown. FLUMIST Quadrivalent started on an unknown date. It is reported that the FLUMIST Quadrivalent administered to pregnant patient. The outcome of the event of administered to pregnant patient was unknown. The report was considered to be non-serious.
L arm -  upper arm middle posterior area reddened, warm, swelling with firmness. Approx. 3" x 5" area. CL alert and active. Encouraged mom to place cool cloth to affected area and give appropriate dose of ibuprofen for discomfort. TC to home x2 (2/17/06 & 2/21/06) with no return of call. No answer.
Pt recvd 1st dose Hep B vax 26SEP91 & 48 hrs following vax pt devel gen pruritus w/swelling & vague chest discomfort; also soreness @ inject site; to MD 30SEP91 w/muscle aches, swelling of neck, difficulty breathing,  chest cong, malaise;
Two days after my second vaccine dose, I woke up to heavy vaginal bleeding and cramping. My period started a full week early with worsened bleeding, cramps and discomfort. My menstrual cycle is typically regular and I was extremely alarmed by this change.